![Andrew Scharenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Scharenberg
Director Ejecutivo en Umoja Biopharma, Inc. .
Cargos activos de Andrew Scharenberg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Umoja Biopharma, Inc.
![]() Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA. | Director Ejecutivo | - | - |
Fundador | - | - | |
Director/Miembro de la Junta | - | 11/05/2022 | |
Presidente | 11/05/2022 | 17/11/2022 | |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Inversor de Capital Privado | 01/06/2019 | - |
Historial de carrera de Andrew Scharenberg
Antiguos cargos conocidos de Andrew Scharenberg.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Casebia Therapeutics LLC
![]() Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | Corporate Officer/Principal | 01/07/2017 | 01/08/2019 |
BLUEBIRD BIO, INC. | Consultor / Asesor | 01/07/2014 | 01/06/2017 |
Cellectis, Inc.
![]() Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Corporate Officer/Principal | 01/07/2011 | 30/06/2014 |
GENERATION BIO CO. | Fundador | 01/03/2017 | - |
Formación de Andrew Scharenberg.
UNC School of Medicine | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Founder | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectorial
Health Technology | 6 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
GENERATION BIO CO. | Health Technology |
Empresas privadas | 4 |
---|---|
Umoja Biopharma, Inc.
![]() Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA. | Health Technology |
Cellectis, Inc.
![]() Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Health Technology |
Casebia Therapeutics LLC
![]() Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | Health Technology |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
- Bolsa de valores
- Insiders
- Andrew Scharenberg
- Experiencia